Protagenic Therapeutics I... (PTIX)
undefined
undefined%
At close: undefined

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00 FY99 FY98 FY97 FY96 FY95
PE Ratio -0.86 -1.92 -4.09 -0.97 -2.05 -2.01 -2.5 -2.91 -0.23 -0.09 -114.51 -0.52 -1.97 -0.61 -16.07 655.57 -5.00K -846.40M -398.25M -1.02K 5.15K 653.34 -1.10K 1.15K -865.03 -10.49B -5.24B
PS Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.38K 0.26 0.84 0.62 1.80 23.71 n/a n/a n/a 39.96 34.32 34.70 39.56 47.53 59.03 317.79M 455.96M
PB Ratio 1.17 1.00 2.05 -2.36 -5.7 -24.33 4.63 2.68 -0.22 -4.74 -6.83 1.27 2.29 1.31 4.02 362.89 -5.00K 690.60M 633.03M 57.65 54.71 55.21 55.92 53.22 55.81 446.89M 419.49M
P/FCF Ratio -1.12 -3.46 -7.3 -2.01 -7.41 -4.79 -4.09 -5.82 -0.29 -0.13 -362.97 -0.92 -15.68 30.55 -12.18 519.69 -10.73K -2.25B 8.07B 1.32K -324.81 2.67K 2.97K -1.49K -146.71 -1.91B -1.63B
P/OCF Ratio -1.16 -3.47 -7.3 -2.01 -7.41 -4.79 -4.09 -5.82 -0.29 -0.13 -362.97 -0.92 -19.23 16.32 -12.8 476.71 -10.73K -2.25B 1.68B 316.37 493.48 211.57 2.24K -1.71K -337.21 -13.68B -5.24B
OCF/S Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -3.81 -0.28 -0.04 0.04 -0.14 0.05 n/a n/a n/a 0.13 0.07 0.16 0.02 -0.03 -0.18 -0.02 -0.09
Debt / Equity Ratio n/a 0.05 0.03 -1.19 -0.44 n/a n/a n/a -1.04 -8.33 -0.15 n/a n/a 0.03 0.01 n/a -0.47 n/a 0.81 0.34 0.36 0.33 0.41 0.28 n/a 0.46 0.27
Quick Ratio 6.41 7.18 13.83 1.34 0.70 0.77 3.17 4.62 0.70 1.74 0.05 1.20 1.93 1.98 2.98 1.16 n/a 15.57 0.36 0.61 0.70 0.83 0.75 0.83 1.66 0.57 0.71
Current Ratio 6.41 7.18 13.83 1.34 0.70 0.77 3.17 4.62 0.70 1.74 0.05 1.20 1.93 1.98 2.98 1.16 n/a 16.17 0.98 1.39 1.42 1.60 1.49 1.72 3.65 1.26 1.46
Asset Turnover n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 0.09 2.07 1.55 1.45 1.54 3.41 n/a n/a n/a 0.86 0.93 0.96 0.82 0.73 0.80 0.79 0.62
Interest Coverage n/a -25.88 -8.33 -10.36 -131.32 -829.44 -170.29 -311.85 -27.28 -325 n/a -1.39K -379.76 -796.53 -249.95 105.29 n/a n/a n/a -1.73 1.70 3.70 n/a n/a -3.36 3.50 5.00
Return on Equity (ROE) -1.36 -0.52 -0.5 2.43 2.79 12.13 -1.85 -0.92 0.96 51.38 0.06 -2.41 -1.16 -2.13 -0.25 0.55 1.00 -0.82 -1.59 -0.06 0.01 0.08 -0.05 0.05 -0.06 -0.04 -0.08
Return on Assets (ROA) -1.16 -0.45 -0.45 -3.18 -2.1 -3.67 -1.27 -0.72 -3.58 -4.39 -1.08 -1.02 -0.66 -1.47 -0.17 0.12 n/a -0.32 -0.57 -0.03 0.01 0.05 -0.03 0.03 -0.05 -0.02 -0.05
Return on Capital (ROIC) -1.23 -0.51 -0.4 -11.39 5.88 10.97 -1.94 -0.9 8.77 -9.29 0.04 -2.46 -1.03 -2.14 -0.33 1.21 1.00 -0.34 -1.59 -0.04 0.06 0.13 -0.02 0.06 -0.05 -0.09 -0.13
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 100.00% -6.7% 22.03% 25.99% 86.44% 96.81% n/a n/a n/a 43.21% 43.27% 44.90% 41.60% 50.04% 46.41% 48.48% 50.72%
Net Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.21K% -49.29% -42.66% -101.65% -11.22% 3.62% n/a n/a n/a -3.92% 0.67% 5.31% -3.59% 4.15% -6.82% -3.03% -8.7%
Pretax Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -948.24% -51.49% -41.77% -102.42% -13.71% 7.40% n/a n/a n/a -4.49% 1.42% 6.26% n/a n/a n/a -5.05% -11.59%
Operating Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -791.76% -55.7% -41.78% -102.82% -14.87% 7.87% n/a n/a n/a -2.84% 3.45% 8.58% -1.47% 5.55% -5.26% -7.07% -14.49%
FCF Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -381.18% -28.21% -5.35% 2.04% -14.81% 4.56% n/a n/a n/a 3.03% -10.57% 1.30% 1.33% -3.2% -40.24% -16.67% -27.97%
EBITDA Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -948.24% -48.35% -36.31% -97.14% -10% 8.41% n/a n/a n/a 8.43% 12.83% 17.42% 8.72% 15.46% 3.67% 3.54% 1.45%